103 related articles for article (PubMed ID: 1608475)
1. The importance and use of iron supplementation in uremia.
Makoff R
Nephrol News Issues; 1992 Jun; 6(6):14-6, 19. PubMed ID: 1608475
[No Abstract] [Full Text] [Related]
2. [Treatment with low doses of intravenous iron does not modify hemoglobin nor the erythropoietin dosage].
Fernández-Gallego J; Martín MA; Alonso A; Toledo R
Nefrologia; 2006; 26(1):143-4. PubMed ID: 16649439
[No Abstract] [Full Text] [Related]
3. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation.
Perazella MA
Am J Kidney Dis; 1995 Dec; 26(6):1000; author reply 1001. PubMed ID: 7503059
[No Abstract] [Full Text] [Related]
4. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation.
Sadjadi SA
Am J Kidney Dis; 1995 Dec; 26(6):1000-1. PubMed ID: 7503060
[No Abstract] [Full Text] [Related]
5. [Iron requirements of hemodialysis patients. Serum ferritin as an indicator].
Hunderi OH
Tidsskr Nor Laegeforen; 1986 Apr; 106(9):738-40. PubMed ID: 3705034
[No Abstract] [Full Text] [Related]
6. Comparative effects of erythropoietin with oral iron in peritoneal dialysis and hemodialysis patients.
Raja R; Bloom E; Johnson R
Adv Perit Dial; 1993; 9():177-80. PubMed ID: 8105918
[TBL] [Abstract][Full Text] [Related]
7. Iron deficiency in patients with dialysis-associated anemia during erythropoietin replacement therapy: strategies for assessment and management.
Van Wyck DB
Semin Nephrol; 1989 Mar; 9(1 Suppl 2):21-4. PubMed ID: 2669082
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin therapy in chronic uremia: the impact of normalization of hematocrit.
Murphy ST; Parfrey PS
Curr Opin Nephrol Hypertens; 1999 Sep; 8(5):573-8. PubMed ID: 10541220
[TBL] [Abstract][Full Text] [Related]
9. Importance of iron status monitoring during erythropoietin treatment in uremic predialysis patients.
Rutkowski B; Debska-Slizień A; Biedunkiewicz B; Bułło B
Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():17-21. PubMed ID: 8192528
[TBL] [Abstract][Full Text] [Related]
10. [Serum ferritin during hemodialysis. II: Outline for iron therapy].
Marco Franco JE; Alarcón Zurita A; Morey Molina A; Pizá Buñola C; Bestard Palmer J; Mairata Bosch S; Galmés Llodra A; Dalmau Diana M
Rev Clin Esp; 1982 Jan; 164(1):11-4. PubMed ID: 7071397
[No Abstract] [Full Text] [Related]
11. [The role of iron deficiency on the development of anemia in patients on regular dialysis therapy].
Zadrazil J; Papajík T; Bachleda P; Budíková M; Novotný D; Scudla V
Vnitr Lek; 1994 Jun; 40(6):362-6. PubMed ID: 8073646
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of anemia in chronically dialyzed patients].
Moynot A
Nephrologie; 1998; 19(3):125-7. PubMed ID: 9633055
[No Abstract] [Full Text] [Related]
13. [Anemia and iron stores in patients during hemodialysis and after renal transplantation [].
Piedras J; Córdova MS; Alvarez-Hernández X; Wadgymar A; Hernández G; Peña JC
Rev Invest Clin; 1982; 34(2):129-32. PubMed ID: 6750733
[No Abstract] [Full Text] [Related]
14. [Parenteral iron substitution for the therapy of anemia in patients under chronic hemodialysis].
Junkers K; Jontofsohn R; Klein G; Heinze V
Med Welt; 1973 Jun; 24(25):1042-4. PubMed ID: 4756334
[No Abstract] [Full Text] [Related]
15. Iron supplementation in renal anemia.
Fishbane S
Semin Nephrol; 2006 Jul; 26(4):319-24. PubMed ID: 16949471
[TBL] [Abstract][Full Text] [Related]
16. The adverse effects of recombinant human erythropoietin therapy.
Wong KC; Li PK; Lui SF; Nicholls MG; Lai KN
Adverse Drug React Acute Poisoning Rev; 1990; 9(4):183-206. PubMed ID: 2088088
[No Abstract] [Full Text] [Related]
17. [Results of treating uremia anemia with human recombinant erythropoietin].
Litwin M; Grenda R; Jelonek A
Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):132-4. PubMed ID: 8090664
[TBL] [Abstract][Full Text] [Related]
18. Iron therapy in hemodialysis patients: time for a reappraisal.
Human LE
JAMA; 1980 Jul; 244(4):371. PubMed ID: 7392133
[No Abstract] [Full Text] [Related]
19. Iron availability is transiently improved by intravenous iron medication in patients on chronic hemodialysis.
Rosenlöf K; Kivivuori SM; Grönhagen-Riska C; Teppo AM; Slimes MA
Clin Nephrol; 1995 Apr; 43(4):249-55. PubMed ID: 7606879
[TBL] [Abstract][Full Text] [Related]
20. Intravenous iron, inflammation, and oxidative stress: is iron a friend or an enemy of uremic patients?
Garneata L
J Ren Nutr; 2008 Jan; 18(1):40-5. PubMed ID: 18089442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
